A review of eslicarbazepine acetate for the adjunctive treatment of partial-onset epilepsy.

J Cent Nerv Syst Dis · 2011 · PMC3663619 · PMID 23861647

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The proportion of seizure-free subjects was higher in the 800-mg (4.8%) and 1200-mg (3.9%) groups compared to the placebo (1.2%) group, but these differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.